Several domains from VAR2CSA can induce Plasmodium falciparum adhesion-blocking antibodies
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Malaria caused by Plasmodium falciparum can result in several different syndromes with severe clinical consequences for the about 200 million individuals infected each year. During pregnancy, women living in endemic areas become susceptible to malaria due to lack of antibodies against a unique P. falciparum membrane protein, named VAR2CSA. This antigen is not expressed in childhood infections, since it binds chondroitin sulphate A (CSA) expressed on the intervillous space in the placenta. A vaccine appears possible because women acquire protective antibodies hindering sequestration in the placenta as a function of parity. A challenge for vaccine development is to design small constructs of this large antigen, which can induce broadly protective antibodies. It has previously been shown that one domain of VAR2CSA, DBL4-FCR3, induces parasite adhesion-blocking antibodies. In this study, it is demonstrated that other domains of VAR2CSA also can induce antibodies with inhibitory activity. METHODS: All VAR2CSA domains from the 3D7 and HB3 parasites were produced in Baculovirus-transfected insect cells. Groups of three rats per protein were immunized and anti-sera were tested for surface reactivity against infected erythrocytes expressing FCR3 VAR2CSA and for the ability to inhibit FCR3CSA parasite adhesion to CSA. The fine specificity of the immune sera was analysed by VAR2CSA peptide arrays. RESULTS: Inhibitory antibodies were induced by immunization with DBL3-HB3 T1 and DBL1-3D7. However, unlike the previously characterised DBL4-FCR3 response the inhibitory response against DBL1-3D7 and DBL3-HB3 T1 was poorly reproduced in the second rounds of immunizations. CONCLUSION: It is possible to induce parasite adhesion-blocking antibodies when immunizing with a number of different VAR2CSA domains. This indicates that the CSA binding site in VAR2CSA is comprised of epitopes from different domains.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Antibodies raised to all DBL domains of 3D7 allele type reduced the adhesion of heterologous FCR3 IE by 50–65% compared to control, with the exception of antibodies to DBL1 that almost completely inhibited FCR3 binding to CSA [49].”
From Designing a VAR2CSA-based vaccine to prevent placental malaria (2015) · cites this paper as [49]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Of the DBL domains of HB3 allele, only DBL3 induced anti-adhesion antibodies that almost completely inhibited the binding of FCR3 IE to CSA [49].”
From Designing a VAR2CSA-based vaccine to prevent placental malaria (2015) · cites this paper as [49]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Su, X.-Z., Heatwole, V. M., Wertheimer, S. P., Guinet, F., Herrfeldt, J. A., Peterson, D. S., Ravetch, J. A., & Wellems, T. E. (1995) · Cell · doi:10.1016/0092-8674(95)90055-1 · Cited by 1,219
Baruch, D. I., Pasloske, B. L., Singh, H. B., Bi, X., Ma, X. C., Feldman, M., Taraschi, T. F., & Howard, R. J. (1995) · Cell · doi:10.1016/0092-8674(95)90054-3 · Cited by 1,030 · cited 1×
“and a high sequence variation among genomes [4-6].”
Smith, J. D., Chitnis, C. E., Craig, A. G., Roberts, D. J., Hudson-Taylor, D. E., Peterson, D. S., Pinches, R., Newbold, C. I., & Miller, L. H. (1995) · Cell · doi:10.1016/0092-8674(95)90056-x · Cited by 1,005 · cited 1×
“and a high sequence variation among genomes [4-6].”
An analysis of malaria in pregnancy in Africa.
Brabin, B. J. (1983) · PubMed Central · Cited by 877
Salanti, A., Staalsoe, T., Lavstsen, T., Jensen, A. T. R., Sowa, M. P. K., Arnot, D. E., Hviid, L., & Theander, T. G. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03570.x · Cited by 702 · cited 1×
“Placental parasites and parasite lines selected for CSA binding in vitro express a unique var gene named var2csa [10,11].”
Self-citationMaternal antibodies block malaria
Fried, M., Nosten, F., Brockman, A., Brabin, B. J., & Duffy, P. E. (1998) · Nature · doi:10.1038/27570 · Cited by 659 · cited 1×
“The mechanism of protection is suggested to be based on antibodies that block binding of IE to CSA [19].”
Bull, P. C., Lowe, B. S., Kortok, M., Molyneux, C. S., Newbold, C. I., & Marsh, K. (1998) · Nature Medicine · doi:10.1038/nm0398-358 · Cited by 645 · cited 1×
“Expression of different PfEMP1 variants allow the parasites to escape previously acquired antibody responses, and clinical protection occurs when a large repertoire of variant specific antibodies allows the host to control the infection [7].”
Evidence for the Involvement of VAR2CSA in Pregnancy-associated Malaria
Salanti, A., Dahlbäck, M., Turner, L., Nielsen, M. A., Barfod, L., Magistrado, P., Jensen, A. T. R., Lavstsen, T., Ofori, M. F., Marsh, K., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041579 · Cited by 604 · cited 11×
“Likewise, high anti-VAR2CSA IgG levels are correlated with protection against the clinical consequences of PAM [13].”
InfluentialSelf-citationJensen, A. T. R., Magistrado, P., Sharp, S., Joergensen, L., Lavstsen, T., Chiucchiuini, A., Salanti, A., Vestergaard, L. S., Lusingu, J. P., Hermsen, R., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040274 · Cited by 322 · cited 1×
“After repeated infections during childhood in endemic areas the acquired repertoire of antibodies against the variant surface antigens will progressively protect against variants expressed during severe, mild and asymptomatic infections [8,9].”
Self-citationFried, M., Muga, R., Misore, A. O., & Duffy, P. E. (1998) · PubMed · Cited by 321
Cited by
Designing a VAR2CSA-based vaccine to prevent placental malaria
Fried, M., & Duffy, P. E. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.10.011 · Cited by 86
“Antibodies raised to all DBL domains of 3D7 allele type reduced the adhesion of heterologous FCR3 IE by 50–65% compared to control, with the exception of antibodies to DBL1 that almost completely inhibited FCR3 binding to CSA [49].”
BackgroundThe Chondroitin Sulfate A-binding Site of the VAR2CSA Protein Involves Multiple N-terminal Domains
Dahlbäck, M., Jørgensen, L. M., Nielsen, M. A., Clausen, T. M., Ditlev, S. B., Resende, M., Pinto, V. V., Arnot, D. E., Theander, T. G., & Salanti, A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.191510 · Cited by 85
Self-citationVar2CSA minimal CSA binding region is located within the N-terminal region
Srivastava, A., Gangnard, S., Dechavanne, S., Amirat, F., Lewit Bentley, A., Bentley, G. A., & Gamain, B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020270 · Cited by 76
“However, adhesion inhibitory activities are not consistent between various DBL4e and DBL5e antigen preparations [31,44].”
BackgroundGhumra, A., Khunrae, P., Ataíde, R., Raza, A., Rogerson, S. J., Higgins, M. K., & Rowe, J. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016414 · Cited by 61
Houngbedji, C. A., N’Dri, P. B., Hürlimann, E., Yapi, R. B., Silué, K. D., Soro, G., Koudou, B. G., Acka, C. A., Assi, S.-B., Vounatsou, P., et al. (2015) · Malaria Journal · doi:10.1186/1475-2875-14-7 · Cited by 67
Cytoadherence and severe malaria.
Craig, A. G., Khairul, M. F. M., & Patil, P. R. (2012) · PubMed · Cited by 83
de Oliveira, D. R., Krettli, A. U., Aguiar, A. C. C., Leitão, G. G., Vieira, M. N., Martins, K. D. S., & Leitão, S. G. (2015) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2015.07.035 · Cited by 53
Magistrado, P. A., Minja, D., Doritchamou, J., Tuikue Ndam, N., John, D., Schmiegelow, C., Massougbodji, A., Dahlbäck, M., Ditlev, S. B., Pinto, V. V., et al. (2011) · Vaccine · doi:10.1016/j.vaccine.2010.10.080 · Cited by 49
Self-citationNielsen, M. A., Resende, M., de Jongh, W. A., Ditlev, S. B., Mordmüller, B., Houard, S., Ndam, N. T., Agerbæk, M. Ø., Hamborg, M., Massougbodji, A., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0135406 · Cited by 48
Self-citationTurner, L., Wang, C. W., Lavstsen, T., Mwakalinga, S., Sauerwein, R. W., Hermsen, C. C., & Theander, T. G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0029025 · Cited by 49
Self-citationPlasmodium falciparum Expressing Domain Cassette 5 Type PfEMP1 (DC5-PfEMP1) Bind PECAM1
Berger, S. S., Turner, L., Wang, C. W., Petersen, J. E. V., Kraft, M., Lusingu, J., Mmbando, B. P., Marquard, A. M., Bengtsson, D. C., Hviid, L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069117 · Cited by 49
“However, cross-reactive antibodies are not necessarily inhibitory as previously shown with anti-VAR2CSA DBL5 antibodies, which often show cross-reactivity against native proteins expressed on different genetic backgrounds in flow cytometry assays but do not inhibit binding [72].”
BackgroundSelf-citationAvril, M., Hathaway, M. J., Srivastava, A., Dechavanne, S., Hommel, M., Beeson, J. G., Smith, J. D., & Gamain, B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016622 · Cited by 40
Progress and Insights Toward an Effective Placental Malaria Vaccine
Gamain, B., Chêne, A., Viebig, N. K., Ndam, N. T., & Nielsen, M. A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.634508 · Cited by 46
“The finding that single DBL domains, which appeared not to bind CSA, could induce inhibitory antibodies was a primary indication that the tertiary structure of the protein was not like DBL-pearls on a string (58, 59).”
BackgroundSelf-citationMultilaboratory Approach to Preclinical Evaluation of Vaccine Immunogens for Placental Malaria
Fried, M., Avril, M., Chaturvedi, R., Fernandez, P., Lograsso, J., Narum, D., Nielsen, M. A., Oleinikov, A. V., Resende, M., Salanti, A., et al. (2013) · Infection and Immunity · doi:10.1128/iai.01106-12 · Cited by 38
“Previous studies reported that immunization with recombinant VAR2CSA domains can elicit antibodies that recognize the surface of homologous (33–35) and heterologous (22, 27, 28, 36, 37) IRBCs.”
BackgroundSelf-citationFernandez, P., Petres, S., Mécheri, S., Gysin, J., & Scherf, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012558 · Cited by 36
Donnelly, B., Berrang‐Ford, L., Labbé, J., Twesigomwe, S., Lwasa, S., Namanya, D. B., Harper, S. L., Kulkarni, M. A., Ross, N. A., & Michel, P. (2016) · Malaria Journal · doi:10.1186/s12936-016-1299-1 · Cited by 47
Doritchamou, J. Y. A., Herrera, R., Aebig, J. A., Morrison, R., Nguyen, V., Reiter, K., Shimp, R. L., MacDonald, N. J., Narum, D. L., Fried, M., et al. (2016) · Journal of Infectious Diseases · doi:10.1093/infdis/jiw197 · Cited by 35
Patel, J. C., Hathaway, N. J., Parobek, C. M., Thwai, K. L., Madanitsa, M., Khairallah, C., Kalilani‐Phiri, L., Mwapasa, V., Massougbodji, A., Fiévet, N., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-04737-y · Cited by 37
Kotepui, M., Kotepui, K. U., Milanez, G. D. J., & Masangkay, F. R. (2020) · Scientific Reports · doi:10.1038/s41598-020-69647-y · Cited by 36
Fried, M., Kurtis, J. D., Swihart, B., Morrison, R., Pond-Tor, S., Barry, A., Sidibe, Y., Keita, S., Mahamar, A., Andemel, N., et al. (2018) · Malaria Journal · doi:10.1186/s12936-018-2258-9 · Cited by 30
Avril, M., Cartwright, M. M., Hathaway, M. J., & Smith, J. D. (2011) · Malaria Journal · doi:10.1186/1475-2875-10-36 · Cited by 35
“To date, few DBL recombinant antigens have induced anti-adhesive antibodies [28,31,32], except for an IT4-DBL4-VAR2CSA recombinant protein produced in Baculovirus [31], and a refolded IT4-DBL5 recombinant protein produced in Escherichia coli [33].”
BackgroundInfluentialSingh, K., Gitti, R. K., Diouf, A., Zhou, H., Gowda, D. C., Miura, K., Ostazeski, S. A., Fairhurst, R. M., Garboczi, D. N., & Long, C. A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.118612 · Cited by 26
Gangnard, S., Lewit-Bentley, A., Dechavanne, S., Srivastava, A., Amirat, F., Bentley, G. A., & Gamain, B. (2015) · Scientific Reports · doi:10.1038/srep14868 · Cited by 25
Pre-clinical and clinical development of the first placental malaria vaccine
Pehrson, C., Salanti, A., Theander, T. G., & Nielsen, M. A. (2017) · Expert Review of Vaccines · doi:10.1080/14760584.2017.1322512 · Cited by 34
“titer anti-adhesive responses, likely due to targeting of epitopes not involved in the binding to CSA [75,76].”
BackgroundSelf-citationKane, E. G., & Taylor-Robinson, A. W. (2011) · Malaria Research and Treatment · doi:10.4061/2011/764845 · Cited by 22
“Whole recombinant VAR2CSA has now been produced, and, although the ability to induce antibodies using this construct has been inconsistent, these findings demonstrate that all domains may be as important as each other in mediating binding and antibody stimulation [103, 104, 227].”
BackgroundMethodPinto, V. V., Ditlev, S. B., Jensen, K. E., Resende, M., Dahlbäck, M., Andersen, G., Andersen, P., Theander, T. G., Salanti, A., & Nielsen, M. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017942 · Cited by 18
“The level of reactivity in this ELISA based peptide array was directly associated to the level of reactivity in an assay where identical peptides were synthesised directly on to a chip, confirming homogeneous coating of the peptides [17].”
BackgroundMethodResultSelf-citationProgress and new horizons toward a VAR2CSA-based placental malaria vaccine
Doritchamou, J., Suurbaar, J., & Ndam, N. T. (2021) · Expert Review of Vaccines · doi:10.1080/14760584.2021.1878029 · Cited by 21
Kotepui, M., Kotepui, K. U., Milanez, G. D. J., & Masangkay, F. R. (2020) · Malaria Journal · doi:10.1186/s12936-020-03292-8 · Cited by 15
Pinto, V. V., Salanti, A., Joergensen, L., Dahlbäck, M., Resende, M., Ditlev, S. B., Agger, E. M., Arnot, D. E., Theander, T. G., & Nielsen, M. A. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.11.068 · Cited by 17
Self-citationVAR2CSA Signatures of High Plasmodium falciparum Parasitemia in the Placenta
Rovira-Vallbona, E., Monteiro, I. F., Bardají, A., Serra‐Casas, E., Neafsey, D. E., Quelhas, D., Valim, C., Alonso, P. L., Dobaño, C., Ordï, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069753 · Cited by 16
Structural insights into chondroitin sulfate binding in pregnancy-associated malaria
Khunrae, P., & Higgins, M. K. (2010) · Biochemical Society Transactions · doi:10.1042/bst0381337 · Cited by 18
Identification and Characterization of B-Cell Epitopes in the DBL4ε Domain of VAR2CSA
Ditlev, S. B., Nielsen, M. A., Resende, M., Agerbæk, M. Ø., Pinto, V. V., Andersen, P. H., Magistrado, P., Lusingu, J., Dahlbäck, M., Theander, T. G., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043663 · Cited by 11
Self-citationDara, A., Travassos, M. A., Adams, M., DeRoo, S. S., Drábek, E. F., Agrawal, S., Laufer, M. K., Plowe, C. V., & da Silva, J. C. F. (2017) · Malaria Journal · doi:10.1186/s12936-017-1976-8 · Cited by 13
Babakhanyan, A., Tutterrow, Y. L., Bobbili, N., Salanti, A., Wey, A. R., Fogako, J., LEKE, R. J. I., Leke, R. G. F., & Taylor, D. W. (2015) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.15-0521 · Cited by 10
Self-citationHow specific is Plasmodium falciparum adherence to chondroitin 4-sulfate?
Goel, S., & Gowda, D. C. (2011) · Trends in Parasitology · doi:10.1016/j.pt.2011.03.005 · Cited by 10
Iyamu, U., Vinals, D. F., Tornyigah, B., Arango, E., Bhat, R., Adra, T. R., Grewal, S., Martin, K., Maestre, A., Overduin, M., et al. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1202276 · Cited by 7
Guillotte-Blisnick, M., Juillerat, A., Igonet, S., Hessel, A., Pêtres, S., Crublet, E., Scanf, C. L., Lewit‐Bentley, A., Bentley, G. A., Vigan-Womas, I., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134292 · Cited by 5
“This differs from reports concerning PfEMP1-Var2CSA indicating substantial inter-animal variability [22, 25, 35] and poor relationship between receptor-binding capacity, induction of surface-reacting antibodies and induction of functionally active, adhesion inhibitory antibodies [32–35, 49, 52, 53].”
BackgroundUsing Population Genetics to Guide Malaria Vaccine Design
Alyssa, E., Beeson, J. G., John, C. F., Freya, J. I., & Arnott, A. (2012) · InTech eBooks · doi:10.5772/34031 · Cited by 5
“var2csa [177-179].”
mSphere of Influence: Structural Insights into the Molecular Mechanism Underlying Placental Malaria
Quintana, M. D. P. (2021) · mSphere · doi:10.1128/msphere.00391-21 · Cited by 2
Brolin, K. (2011) · Figshare
Rovira-Vallbona, E. (2011) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Hakim, T. A., Arimdayu, A. R., Ma’ruf, I. F., Mayasari, W., & Wiraswati, H. L. (2023) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2023.00655
Metadata
- Authors
- Salanti, A., Resende, M., Ditlev, S. B., Pinto, V. V., Dahlbäck, M., Andersen, G., Manczak, T., Theander, T. G., & Nielsen, M. A.
- Affiliations
- University of Copenhagen (DK)
- Corresponding author
- Salanti, Ali
- Venue
- Malaria Journal
- Published
- 2010-01-11
- Volume
- 9
- Issue
- 1
- Pages
- 11-11
- ISSN
- 1475-2875 (ISSN-L)
- PMC
- PMC2817698
- OpenAlex
- W2159968240
- Cited by
- 42
- References
- 30
- Citations by year
- 2023: 2 · 2021: 3 · 2020: 2 · 2018: 1 · 2017: 3 · 2016: 2 · 2015: 7 · 2013: 2 · 2012: 4
- FWCI
- 6.97
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/2.0 (tdm)
- Locations
- Malaria Journal (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Funders
- Bill and Melinda Gates Foundation
- European Commission (201222)
- Danmarks Frie Forskningsfond
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Health Sciences › Medicine › Hematology › Blood groups and transfusion
- Life Sciences › Immunology and Microbiology › Parasitology › Vector-borne infectious diseases
- Keywords
- VAR2CSA, Plasmodium falciparum, placental malaria, chondroitin sulfate A, DBL domains, placental sequestration, malaria vaccine, epitope mapping
- MeSH terms
- Animals, Antibodies, Protozoan, Antigens, Protozoan, Cell Adhesion, Female, Genetic Vectors, Humans, Insecta, Pregnancy, Vaccines, Synthetic, Baculoviridae, Rats, Wistar, Protein Structure, Tertiary, Malaria Vaccines, Vaccines, Subunit, Rats, Antibodies, Neutralizing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.